CYP2C8-Mediated Drug-Drug Interactions and the Factors Influencing the Interaction Magnitude. [PDF]
Zhu LL, Yu LY, Wang YH, Zhou Q.
europepmc +1 more source
Unraveling enantioselective metabolism: Human cytochrome P450s in arachidonic acid biotransformation. [PDF]
Isse FA, El-Sherbeni AA, El-Kadi AOS.
europepmc +1 more source
Regulation of P450-derived epoxy fatty acids in cardiovascular diseases. [PDF]
Edin ML, Graves JP, Zeldin DC.
europepmc +1 more source
Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model. [PDF]
Pacsuta J +6 more
europepmc +1 more source
Distinct Single-Cell Expression Pattern of the Soluble Epoxide Hydrolase and Cytochrome p450 Epoxygenases in Human and Mouse Small Intestinal Epithelia. [PDF]
Sun L, Tang A, Liao J, Yang GY.
europepmc +1 more source
A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11. [PDF]
Davydov DR +4 more
europepmc +1 more source
Curcumin Successfully Inhibited the Computationally Identified CYP2A6 Enzyme-Mediated Bioactivation of Aflatoxin B1 in Arbor Acres broiler [PDF]
He Wang +8 more
core +1 more source
<i>CYP2D6</i> polymorphism rs1065852 significantly increases the risk of type 2 diabetes. [PDF]
Wei H, Zhao Q.
europepmc +1 more source
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil. [PDF]
Aurinsalo L +7 more
europepmc +1 more source
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein Inhibition. [PDF]
Jia H +7 more
europepmc +1 more source

